Subscribe to RSS
DOI: 10.1055/s-2004-832807
Synthesis and Reactions of Allenic Sulfone-Modified Thymidine: The First Allenic Sulfone to Alkylate Deoxyadenosine
Publication History
Publication Date:
21 September 2004 (online)

Abstract
3′-(S)-(allenic sulfonyl)-5′-benzoyl-3′-deoxythymidine has been synthesized from 1-(5-O-trityl-3-O-mesyl-2-deoxy-β-d-threopentofuranosyl) thymine via 3′-(S)-(propargylthio)-5′-trityl-3′-deoxythymidine in six steps. 3′-(S)-(allenic sulfonyl)-3′-deoxythymidine reacts very efficiently with a wide array of nucleophiles. This is also the first report on the alkylation of adenine moiety by some allenic sulfone modified compounds.
Key words
reactive nucleosides - allenic sulfone - alkylating nucleoside
- 1 Present address: New River Pharmaceuticals, 1861 Pratt Drive, Suite 1090, Blacksburg, VA 24060, USA
- For a discussion on the importance of alkylating agents in biological systems, see:
-
2a
Silverman RB. The Organic Chemistry of Drug Design and Drug Action Elsevier; Amsterdam, Boston: 2004. Chap. 5. -
2b
Silverman RB. The Organic Chemistry of Drug Design and Drug Action Elsevier; Amsterdam, Boston: 2004. Chap. 6. -
3a
Lyttle DA.Petering HG. J. Am. Chem. Soc. 1958, 80: 6459 -
3b
Evans JS.Mengel GD. Proc. Soc. Exptl. Biol. Med. 1958, 99: 620 -
3c
Kennedy BJ.Torkelson JL.Torlakovic E. Cancer 1999, 85: 2265 -
4a
De las Heras FG.Alonso R.Alonso G. J. Med. Chem. 1979, 22: 496 -
4b
Alonso R.Camarasa MJ.Alonso G.De las Heras FG. Eur. J. Med. Chem. 1980, 15: 105 -
4c
De las Heras FG.Sanchez-Perez RM.Aguado ML. Eur. J. Med. Chem. 1981, 16: 339 -
4d
Garcia-Lopez MT.Herranz R.Mendez-Castrillon PP. Nucleosides Nucleotides 1982, 1: 127 -
4e
Garcia-Lopez MT.Herranz R.Andres JI. J. Chem. Soc., Perkin Trans. 1 1983, 2303 - 5
Talebian AH.Schein PS.Green DC.Vincent T. Nucleosides Nucleotides 1990, 9: 721 - 6
Schreiber SL.Ikemoto N. Tetrahedron Lett. 1988, 29: 3211 -
7a
Catalano CE.Benkovic SJ. Biochemistry 1989, 28: 4374 -
7b
Semizarov DG.Victorova LS.Krayevsky AA.Kukhanova MK. FEBS Lett. 1993, 327: 45 -
7c
Gurskaya GV.Bochkarev AV.Zdanov AS.Papchikhin AV.Purygin PP.Kraevskii AA. FEBS Lett. 1990, 265: 63 -
8a
Bera S.Sakthivel K.Pathak T.Langley GJ. Tetrahedron 1995, 51: 7857 -
8b
Bera S.Langley GJ.Pathak T. J. Org. Chem. 1998, 63: 1754 -
8c
Pathak T. Eur. J. Org. Chem. 2004, 3361 - 9 For a review on allenic sulfones, see:
Back TG. Tetrahedron 2001, 57: 5263 -
10a
Nicolaou KC.Wendeborn S.Isshiki K.Zein N.Ellestad G. Angew. Chem., Int. Ed. Engl. 1991, 30: 418 -
10b
Dai W.-M.Chow CW.Zhou L.Ishii A.Lau CW.Li Q.Hamaguchi W.Nishimoto S.-I. Bioorg. Med. Chem. 1999, 9: 2789 -
10c
McPhee MM.Kern JT.Hoster BC.Kerwin SM. Bioorg. Chem. 2000, 28: 98 -
10d
McPhee MM.Kerwin SM. Bioorg. Med. Chem. 2001, 9: 2809 -
10e
Braverman S.Cherkinsky M.Birsa ML.Zafrani Y. Eur. J. Org. Chem. 2002, 3198 -
10f
Suzuki I.Shigenaga A.Manabe A.Nemoto H.Shibuya M. Tetrahedron 2003, 59: 5691 -
10g
Haruna K.-i.Tanabe K.Ishii A.Min-Dai W.Hatta H.Nishimoto S.-i. Bioorg. Med. Chem. 2003, 11: 5311 - 11
Herdewijn P.Balzarini J.Baba M.Pauwels R.Aerschot AV.Janssen G.Clercq ED. J. Med. Chem. 1988, 31: 2040 -
14a
Mackle H.Steele WV. Trans. Faraday Soc. 1969, 65: 2073 -
14b
Back TG.Parvez M.Wulff JE. J. Org. Chem. 2003, 68: 2223
References
Compound 9: 1H NMR (360 MHz, CDCl3 + D2O): δ = 7.55 (s, 1 H, H-6), 6.13 (dd, J = 4.7, 7.0 Hz, 1 H, H-1′), 4.06-3.96 (m, 2 H), 3.87 (dd, J = 2.6, 11.9 Hz, 1 H), 3.73 (q, 1 H, J = 7.9 Hz), 3.36 (m, 2 H, SCH2), 2.65 (m, 1 H), 2.51 (m, 1 H), 2.32 (t, J = 2.6 Hz, 1 H, acetylenic), 1.91 (s, 3 H, CH3). 13C NMR (90 MHz, CDCl3): δ = 164.2, 150.5, 136.6, 110.7, 85.5 (C-1′), 85.5 (acetylene), 79.6 (C-4′), 72.0 (acetylene), 61.3 (C-5′), 40.9 (C-3′), 39.6 (C-2′), 19.4 (SCH2), 12.4 (CH3). HRMS (FAB+): m/z calcd for C13H17N2O4S [M + H]+: 297.0909; found: 297.0911.
13Compound 12: mp 86-87 °C. 1H NMR (360 MHz, CDCl3): δ = 9.67 (s, 1 H, NH), 8.01-7.41 (m, 5 H, phenyl), 7.15 (s, 1 H, H-6), 6.26 (t, J = 6.2 Hz, 1 H, allene CH), 6.07 (t, J = 6.5 Hz, 1 H, H-1′), 5.59 (m, 2 H, =CH2), 4.79 (m, 2 H, H-4′, H-5′a), 4.56 (dd, J = 4.1, 12.2 Hz, 1 H, H-5′b), 4.07 (m, 1 H, H-3′), 2.97 (m, 1 H, H-2′a), 2.52 (m, 1 H, H-2′b), 1.64 (s, 3 H, CH3). 13C NMR (90 MHz, CDCl3): δ = 211.8 (=C=), 165.9 (ester CO), 163.8 (C-4), 150.1 (C-2), 135.4 (C-6), 133.6, 129.5, 129.1, 128.6 (phenyl), 111.3 (C-5), 96.3 (HC=), 86.5 (C-1′), 84.3 (=CH2), 77.0 (C-4′), 64.7 (C-5′), 63.7 (C-3′), 33.4 (C-2′), 12.1 (CH3). HRMS (FAB+): m/z calcd for C20H21N2O7S [M + H]+: 433.1061; found: 433.1061.
15Methoxide ion adds to MeCCSO2Ph to produce MeC(OMe)2CH2SO2Ph, see ref. [8]
16Compound 15: mp 169-170 °C. 1H NMR (360 MHz, DMSO-d 6): δ = 11.38 (s, 1 H), 8.30-7.08 (m, 10 H), 6.22 (t, J = 6.5 Hz, 1 H), 4.73-4.37 (m, 4 H), 2.83 (m, 1 H), 2.69 (s, 3 H), 2.64 (m, 1 H), 1.56 (s, 3 H). 13C NMR (90 MHz, DMSO-d 6): δ = 165.4 (benzoyl CO), 163.5, 150.3, 148.5, 136.5, 135.5, 133.6, 130.5, 129.3, 129.1, 128.8, 117.4, 111.7, 110.0, 84.3, 75.3, 65.1 (C-5′), 63.4, 31.4 (C-2′), 15.4, 11.8. HRMS (FAB+): m/z calcd for C23H25N4O7S [M + H]+: 501.1444; found: 501.1449. Compound 16: mp 103-104 °C. 1H NMR (360 MHz, CDCl3): δ = 10.57 (br s, 1 H), 7.95-7.02 (m, 9 H), 5.98 (t, J = 6.4 Hz, 1 H), 5.52 (s, 1 H), 5.37 (s, 1 H), 4.82 (m, 1 H), 4.69 (d, J = 12.2 Hz, 1 H), 4.58 (d, J = 14.7 Hz, 1 H), 4.50 (dd, J = 4.2, 12.2 Hz, 1 H), 4.33 (d, J = 14.7 Hz, 1 H), 3.86 (m, 1 H), 2.96 (m, 1 H), 2.33 (m, 1 H), 1.58 (s, 3 H). 13C NMR (90 MHz, CDCl3): δ = 165.9, 164.1, 150.5, 136.1, 135.4, 133.6, 130.4, 130.0, 129.5, 129.0, 128.6, 118.0, 114.1 (=CH2), 111.2, 86.5, 75.8, 64.9 (C-5′), 60.8, 56.8 (SO2CH2), 33.5 (C-2′), 12.1. HRMS (FAB+): m/z calcd for C23H25N4O7S [M + H]+: 501.1444; found: 501.1431.
17Compound 20: A solution of 12 (0.140 g, 0.32 mmol) and 2′-deoxyadenosine (0.095 g, 0.36 mmol) in dioxane (15 mL) was stirred at r.t. for 2 d. Solvent was evaporated to dryness and the residue was purified over silica gel to give 19. Ac2O (0.6 mL, 6.40 mmol) was added to a solution of 19 in pyridine (15 mL) and the mixture was stirred at r.t. After 15 h the reaction mixture was worked-up in the usual way and the product was purified over silica gel to give 20 (0.120 g, 46%); mp 137-138 °C. 1H NMR (360 MHz, CDCl3): δ = 9.52 (s, 1 H), 7.97-7.07 (m, 8 H), 6.27 (dd, J = 6.1, 8.0 Hz, 1 H), 5.93 (t, J = 6.8 Hz, 1 H), 5.83 (s, 1 H), 5.66 (s, 1 H), 5.33 (m, 1 H), 4.79-4.12 (m, 9 H), 2.88-2.73 (m, 2 H), 2.58 (m, 2 H), 2.27 (s, 3 H), 2.09 (s, 3 H), 2.05 (s, 3 H), 1.61 (s, 3 H). 13C NMR (90 MHz, CDCl3): δ = 184.0, 170.4, 170.2, 165.9, 163.6, 149.9, 147.4, 144.2, 143.2, 138.0, 136.0, 134.5, 133.5, 129.6, 129.1, 128.6, 124.7 (=CH2), 121.2, 111.2, 87.1, 84.4, 82.7, 76.1, 74.3, 64.8 (CH2), 63.6 (C-5′, CH2), 61.3, 55.1 (CH2), 37.8 (CH2), 33.6 (CH2), 26.5, 20.8, 20.7 (2 peaks), 12.1. HRMS (FAB+): m/z calcd for C36H40N7O13S [M + H]+: 810.2405; found: 810.2410.